<p>Evolent Health（纽约证券交易所代码：EVH - 获取免费报告）预计将在 2025 年 2 月 24 日星期二市场收盘后发布其 2025 年第四季度财报。分析师预计 Evolent Health 本季度每股收益为 0.06 美元，收入为 4.68481 亿美元。个人可以访问该公司即将发布的 2025 年第四季度财报页面，以获取关于定于 2026 年 2 月 24 日下午 5:00（东部时间）电话会议的最新详情。</p>
<p>获取 <strong>Evolent Health</strong> 警报：</p>
<h2>Evolent Health 价格表现</h2>
<p>纽约证券交易所 EVH 的股票在星期二开盘价为 2.79 美元。该公司的债务与股本比率为 1.25，速动比率为 1.33，流动比率为 1.33。Evolent Health 的年内最低价为 2.56 美元，年内最高价为 12.06 美元。该公司的 50 日移动平均价为 3.69 美元，200 日移动平均价为 6.16 美元。该公司的市值为 3.1081 亿美元，市盈率为-1.76，贝塔值为 0.27。</p>
<h2>机构投资者对 Evolent Health 的看法</h2>
<p>机构投资者和对冲基金最近调整了对该股票的持有。Brighton Jones LLC 在第四季度以约 392.7 万美元的估值收购了 Evolent Health 的新头寸。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Evolent Health 的持股增加了 2.9%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.目前拥有 128,527 股该科技公司的股票，价值 121.7 万美元，此前在上个季度又购买了 3,572 股。高盛集团在第一季度将其在 Evolent Health 的持股增加了 162.2%。高盛集团目前拥有 2,836,402 股该科技公司的股票，价值 2686.1 万美元，此前在此期间又购买了 1,754,520 股。Caxton Associates LLP 在第一季度收购了 Evolent Health 的新股份，估值为 252,000 美元。最后，Strs Ohio 在第一季度购买了 Evolent Health 的新头寸，估值为 47,000 美元。</p>
<h2>分析师评级变动</h2>
<p>几位分析师最近对 EVH 股票发表了看法。Truist Financial 在 11 月 10 日的研究报告中将 Evolent Health 的目标价从 16.00 美元下调至 10.00 美元，并给予该公司 “买入” 评级。花旗集团在 1 月 9 日的报告中将 Evolent Health 的目标价从 9.50 美元下调至 6.00 美元，并对该股票给予 “买入” 评级。Piper Sandler 在 12 月 2 日的研究报告中对 Evolent Health 的股票设定了 6.00 美元的目标价。BTIG Research 在 2 月 2 日的研究报告中将 Evolent Health 的目标价从 16.00 美元下调至 10.00 美元，并给予该公司 “买入” 评级。最后，Weiss Ratings 在 12 月 29 日的报告中重申了对 Evolent Health 的 “卖出（e+）” 评级。十三位研究分析师对该股票给予了买入评级，一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，共识目标价为 9.77 美元。</p>
<p><strong>获取我们关于 EVH 的最新报告</strong></p>
<h2>Evolent Health 公司简介</h2>
<p>（获取免费报告）</p>
<p>Evolent Health, Inc 是一家总部位于美国的医疗科技和服务公司，与医疗系统、医生组织和健康计划合作，设计、构建和运营基于价值的护理项目。该公司总部位于弗吉尼亚州阿灵顿，成立于 2011 年，是 TPG 与匹兹堡大学医疗中心（UPMC）之间的合资企业。Evolent Health 旨在通过利用其专有技术平台和临床专业知识，帮助客户从按服务收费的支付模式过渡到基于价值的护理安排。</p>
<p>该公司的核心产品包括护理管理解决方案、人口健康分析和临床咨询服务。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们更看好的股票比 Evolent Health 更好</li>
<li>你的银行账户不再安全</li>
<li>Nvidia CEO 发出大胆的特斯拉预测</li>
<li>在 2026 年 5 月之前购买这只黄金股票</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>这只 15 美元的股票可能会成为 2026 年的第一只股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVWSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVWSA"/></p>
<p><em>此即时新闻警报由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Evolent Health 吗？</h2>
<p>在你考虑 Evolent Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Evolent Health 并不在名单上。</p>
<p>虽然 Evolent Health 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

标普软件与服务 ETF - SPDR

<p>Evolent Health（纽约证券交易所代码：EVH）将于 2 月 24 日公布 2025 年第四季度财报，预计每股收益为 0.06 美元，收入为 4.6848 亿美元。该公司股票开盘价为 2.79 美元，市值为 3.1081 亿美元。分析师的评级不一，普遍评级为 “适度买入”，目标价为 9.77 美元。近期的机构投资包括 Brighton Jones LLC 和高盛集团。Evolent Health 专注于医疗技术和服务，帮助客户过渡到基于价值的医疗模式</p>

<p>Evolent Health (NYSE:EVH - Get Free Report) is expected to post its Q4 2025 results after the market closes on Tuesday, February 24th. Analysts expect Evolent Health to post earnings of $0.06 per share and revenue of $468.4810 million for the quarter. Individuals may visit the the company's upcoming Q4 2025 earning results page for the latest details on the call scheduled for Tuesday, February 24, 2026 at 5:00 PM ET.</p>
<div class="lb-trans"><p>Evolent Health（纽约证券交易所代码：EVH - 获取免费报告）预计将在 2025 年 2 月 24 日星期二市场收盘后发布其 2025 年第四季度财报。分析师预计 Evolent Health 本季度每股收益为 0.06 美元，收入为 4.68481 亿美元。个人可以访问该公司即将发布的 2025 年第四季度财报页面，以获取关于定于 2026 年 2 月 24 日下午 5:00（东部时间）电话会议的最新详情。</p>
</div><p>Get <strong>Evolent Health</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Evolent Health</strong> 警报：</p>
</div><h2>Evolent Health Price Performance</h2>
<div class="lb-trans"><h2>Evolent Health 价格表现</h2>
</div><p>Shares of NYSE EVH opened at $2.79 on Tuesday. The company has a debt-to-equity ratio of 1.25, a quick ratio of 1.33 and a current ratio of 1.33. Evolent Health has a one year low of $2.56 and a one year high of $12.06. The company's fifty day moving average is $3.69 and its two-hundred day moving average is $6.16. The firm has a market capitalization of $310.81 million, a P/E ratio of -1.76 and a beta of 0.27.</p>
<div class="lb-trans"><p>纽约证券交易所 EVH 的股票在星期二开盘价为 2.79 美元。该公司的债务与股本比率为 1.25，速动比率为 1.33，流动比率为 1.33。Evolent Health 的年内最低价为 2.56 美元，年内最高价为 12.06 美元。该公司的 50 日移动平均价为 3.69 美元，200 日移动平均价为 6.16 美元。该公司的市值为 3.1081 亿美元，市盈率为-1.76，贝塔值为 0.27。</p>
</div><h2>Institutional Investors Weigh In On Evolent Health</h2>
<div class="lb-trans"><h2>机构投资者对 Evolent Health 的看法</h2>
</div><p>Institutional investors and hedge funds have recently modified their holdings of the stock. Brighton Jones LLC acquired a new position in shares of Evolent Health in the 4th quarter valued at about $3,927,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Evolent Health by 2.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 128,527 shares of the technology company's stock worth $1,217,000 after buying an additional 3,572 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of Evolent Health by 162.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,836,402 shares of the technology company's stock valued at $26,861,000 after buying an additional 1,754,520 shares during the period. Caxton Associates LLP acquired a new stake in shares of Evolent Health during the 1st quarter valued at $252,000. Finally, Strs Ohio purchased a new position in shares of Evolent Health during the 1st quarter valued at $47,000.</p>
<div class="lb-trans"><p>机构投资者和对冲基金最近调整了对该股票的持有。Brighton Jones LLC 在第四季度以约 392.7 万美元的估值收购了 Evolent Health 的新头寸。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Evolent Health 的持股增加了 2.9%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.目前拥有 128,527 股该科技公司的股票，价值 121.7 万美元，此前在上个季度又购买了 3,572 股。高盛集团在第一季度将其在 Evolent Health 的持股增加了 162.2%。高盛集团目前拥有 2,836,402 股该科技公司的股票，价值 2686.1 万美元，此前在此期间又购买了 1,754,520 股。Caxton Associates LLP 在第一季度收购了 Evolent Health 的新股份，估值为 252,000 美元。最后，Strs Ohio 在第一季度购买了 Evolent Health 的新头寸，估值为 47,000 美元。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>Several analysts have recently weighed in on EVH shares. Truist Financial lowered their target price on Evolent Health from $16.00 to $10.00 and set a &#34;buy&#34; rating for the company in a research note on Monday, November 10th. Citigroup dropped their price objective on Evolent Health from $9.50 to $6.00 and set a &#34;buy&#34; rating on the stock in a report on Friday, January 9th. Piper Sandler set a $6.00 price target on shares of Evolent Health in a research report on Tuesday, December 2nd. BTIG Research dropped their price target on shares of Evolent Health from $16.00 to $10.00 and set a &#34;buy&#34; rating for the company in a research note on Monday, February 2nd. Finally, Weiss Ratings reaffirmed a &#34;sell (e+)&#34; rating on shares of Evolent Health in a report on Monday, December 29th. Thirteen research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $9.77.</p>
<div class="lb-trans"><p>几位分析师最近对 EVH 股票发表了看法。Truist Financial 在 11 月 10 日的研究报告中将 Evolent Health 的目标价从 16.00 美元下调至 10.00 美元，并给予该公司 “买入” 评级。花旗集团在 1 月 9 日的报告中将 Evolent Health 的目标价从 9.50 美元下调至 6.00 美元，并对该股票给予 “买入” 评级。Piper Sandler 在 12 月 2 日的研究报告中对 Evolent Health 的股票设定了 6.00 美元的目标价。BTIG Research 在 2 月 2 日的研究报告中将 Evolent Health 的目标价从 16.00 美元下调至 10.00 美元，并给予该公司 “买入” 评级。最后，Weiss Ratings 在 12 月 29 日的报告中重申了对 Evolent Health 的 “卖出（e+）” 评级。十三位研究分析师对该股票给予了买入评级，一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，共识目标价为 9.77 美元。</p>
</div><p><strong>Get Our Latest Report on EVH</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 EVH 的最新报告</strong></p>
</div><h2>Evolent Health Company Profile</h2>
<div class="lb-trans"><h2>Evolent Health 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Evolent Health, Inc is a U.S.-based healthcare technology and services company that partners with health systems, physician organizations and health plans to design, build and operate value-based care programs. Headquartered in Arlington, Virginia, the company was founded in 2011 as a joint venture between TPG and the University of Pittsburgh Medical Center (UPMC). Evolent Health aims to help its clients transition from fee-for-service payment models to value-based care arrangements by leveraging its proprietary technology platforms and clinical expertise.</p>
<div class="lb-trans"><p>Evolent Health, Inc 是一家总部位于美国的医疗科技和服务公司，与医疗系统、医生组织和健康计划合作，设计、构建和运营基于价值的护理项目。该公司总部位于弗吉尼亚州阿灵顿，成立于 2011 年，是 TPG 与匹兹堡大学医疗中心（UPMC）之间的合资企业。Evolent Health 旨在通过利用其专有技术平台和临床专业知识，帮助客户从按服务收费的支付模式过渡到基于价值的护理安排。</p>
</div><p>The company's core offerings include care management solutions, population health analytics and clinical advisory services.</p>
<div class="lb-trans"><p>该公司的核心产品包括护理管理解决方案、人口健康分析和临床咨询服务。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Evolent Health</li>
<li>Your Bank Account Is No Longer Safe</li>
<li>Nvidia CEO Issues Bold Tesla Call</li>
<li>Buy this Gold Stock Before May 2026</li>
<li>What a Former CIA Agent Knows About the Coming Collapse</li>
<li>This $15 Stock Could Go Down as the #1 Stock of 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票比 Evolent Health 更好</li>
<li>你的银行账户不再安全</li>
<li>Nvidia CEO 发出大胆的特斯拉预测</li>
<li>在 2026 年 5 月之前购买这只黄金股票</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>这只 15 美元的股票可能会成为 2026 年的第一只股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVWSA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NYSE&amp;Symbol=EVH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻警报由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Evolent Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Evolent Health 吗？</h2>
</div><p>Before you consider Evolent Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Evolent Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evolent Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Evolent Health 并不在名单上。</p>
</div><p>While Evolent Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Evolent Health 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Evolent Health (EVH) 预计将在周二宣布季度财报